CLINICAL_TRIALS
trial_result
· 2015-06-04
Clinical Trial Update: Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Summary
Phase 2 trial of ofatumumab in patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma has completed, with results posted …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SCRI Development Innovations, LLC | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2015-06-04